BMB has secured a strong position in novel resin-based implants via granted patents in Europe and pending approval of patents in other key regions.
The Patents protect the company's core technology, Bonevolent® in several aspects and it is used to innovate implant applications.
It has been a key priority to reach these milestones to secure the foundation of the company’s goal of being a leader in this new field of implant solutions and lay ground for future expansion.
